1229931

Janssen Pharmaceuticals, Inc — FEI 2242843

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System